| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/24/1993 | EP0527771A1 Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals |
| 02/24/1993 | EP0527767A1 Self-polymerising expression system based on modified potyvirus coat proteins |
| 02/24/1993 | CN1069286A Production of pradimicin antibiotics |
| 02/23/1993 | WO1993004090A1 Hiv immunotherapeutics |
| 02/23/1993 | US5189150 Oasomycins |
| 02/23/1993 | CA1313875C 4-¬4-¬4-¬4-¬¬2-(2,4-difluorophenyl)-2-(1h-azolylmethyl)-1, 3-dioxolan-4-y1|methoxy|phenyl|-1-piperazinyl|phenyl| triazolones |
| 02/21/1993 | CA2073138A1 Use of 9,12,15-octadecatriene-6-ynoic acid |
| 02/18/1993 | WO1993003145A1 Infectious bursal disease virus recombinant poxvirus vaccine |
| 02/18/1993 | WO1993003060A1 Amide derivatives of antibiotic a 40926 |
| 02/18/1993 | WO1993003057A1 Polypeptides capable of in vivo induction of antibodies themselves capable of inhibiting the invasion of red blood corpuscles by merozoites of p.falciparum, related products and their use in producing vaccine compositions |
| 02/18/1993 | WO1993003030A1 Quinoline derivatives as immunostimulants |
| 02/18/1993 | WO1993003028A1 Furylthiazole and their use as h2-receptor antagonism and antimicrobial |
| 02/18/1993 | WO1993003027A1 1,3-oxathiolane nucleoside analogues |
| 02/18/1993 | WO1993003022A1 Compounds and methods for inhibition of hiv and related viruses |
| 02/18/1993 | WO1993002709A1 Receptor conjugates for targeting drugs and other agents |
| 02/18/1993 | WO1993002703A1 Prodrugs activated by targeted catalytic proteins |
| 02/18/1993 | WO1993002693A2 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 02/18/1993 | WO1993002662A1 Antiviral pharmaceutical compositions for vaginal administration |
| 02/18/1993 | CA2114934A1 Prodrugs activated by targeted catalytic proteins |
| 02/18/1993 | CA2114651A1 Furylthiazole and their use as h2-receptor antagonism and antimicrobial |
| 02/18/1993 | CA2114223A1 Polypeptides capable of in vivo induction of antibodies themselves capable of inhibiting the invasion of red blood corpuscles by merozoites of p. falciparum, related products and their use in producing vaccine compositions |
| 02/18/1993 | CA2114216A1 Antiviral pharmaceutical compositions for vaginal administration |
| 02/18/1993 | CA2110505A1 Infectious bursal disease virus recombinant poxvirus vaccine |
| 02/17/1993 | EP0527686A1 New cephalosporin derivatives |
| 02/17/1993 | EP0527189A1 Novel cc-1065 analogs |
| 02/17/1993 | CA2076204A1 Hiv protease inhibitors with n-terminal polyether substituents |
| 02/17/1993 | CA2075666A1 Hiv protease inhibitors useful for the treatment of aids |
| 02/16/1993 | US5187286 Antiinflammatory agents, antiallergens |
| 02/16/1993 | US5187160 7-(2-(aminothiazol-4-yl)-2-alkoxyiminoacetamido),3-(2 -hydroxyalkylpyrazol-2-ium-2-yl)methyl)-3-cephem carboxylate; microbiocides |
| 02/16/1993 | US5187089 Variants wherein there are nonpolar amino acid substitutions at the substrate binding site |
| 02/16/1993 | US5187087 Recominbant herpesvirus of turkeys and live vector vaccines derived thereof |
| 02/16/1993 | CA1313654C Cephalosporins containing a substituted vinyl radical in 3; process for preparing the same; their use as drugs; compositions containing them and new intermediates produced |
| 02/11/1993 | CA2075547A1 Trifluoromethyl-containing pseudopeptides |
| 02/10/1993 | EP0526906A1 Process for producing 3-deacylated derivatives of a 16-membered macrolide antibiotic, microorganism to be used therefor and novel macrolide antibiotic |
| 02/10/1993 | EP0526695A1 Stabilized PVP-I solutions |
| 02/10/1993 | EP0526570A1 Composition and treatment with biologically active peptides and anti-parasitic agents or anti-fungal agents |
| 02/10/1993 | EP0526543A1 Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents |
| 02/10/1993 | EP0526452A1 Hybrid immunoglobulins |
| 02/10/1993 | CN1068814A Tetracyclic antibiotic and process for preparing same |
| 02/10/1993 | CN1068813A Pleuromutilin complexes |
| 02/10/1993 | CN1068744A Asialoglycoprotein-conjugated medicinal agent |
| 02/10/1993 | CN1068739A Improved oral dosing formulations of dideoxy purine nucleosides |
| 02/10/1993 | CN1068736A Process for preparing antifungal composition for external application |
| 02/09/1993 | US5185377 Applying locally or by inhalation as antiinflammatory agent, antiallergen, bronchodilator, antiasthmatic, antipsoriatic |
| 02/09/1993 | US5185324 Enzyme-inhibiting amino acid derivatives, a process for the preparation thereof, agents containing these, and the use thereof |
| 02/09/1993 | CA2075459A1 Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as hmg-coa reductase inhibitors |
| 02/09/1993 | CA2014033C Compositions and treatments for pneumonia in animals |
| 02/09/1993 | CA1313498C 3'-azido-2', 3'-dideoxyuridine anti-retroviral composition |
| 02/04/1993 | WO1993002191A1 Humanized antibody against cd18 |
| 02/04/1993 | WO1993002184A1 Papilloma virus vaccine |
| 02/04/1993 | WO1993002087A1 Gallium (iii) complexes, process for their obtention and pharmaceutical compositions containing them |
| 02/04/1993 | WO1993002058A1 Benzimidazole anthelmintics |
| 02/04/1993 | WO1993002057A1 Retroviral protease inhibitors |
| 02/04/1993 | WO1993001833A1 Improved vaccine |
| 02/04/1993 | WO1993001828A1 Lipid conjugates of therapeutic peptides and protease inhibitors |
| 02/04/1993 | WO1993001818A1 Antimicrobial treatment methods and compositions |
| 02/04/1993 | WO1993001800A1 Therapeutic compositions and methods |
| 02/04/1993 | WO1993001723A1 Prophylaxis and treatment of adverse oral conditions with biologically active peptides |
| 02/04/1993 | CA2114122A1 Therapeutic compositions and methods |
| 02/04/1993 | CA2113644A1 Retroviral protease inhibitors |
| 02/04/1993 | CA2113614A1 Antimicrobial treatment methods and compositions |
| 02/04/1993 | CA2113572A1 Improved vaccine |
| 02/04/1993 | CA2113156A1 Lipid conjugates of therapeutic peptides and protease inhibitors |
| 02/03/1993 | EP0526258A2 A87689 Compounds, their production and use as phospholipase-A2 inhibitors |
| 02/03/1993 | EP0526253A1 1,3-Oxathiolane nucleoside analogues |
| 02/03/1993 | EP0526009A1 Inhibitors of hiv protease useful for the treatment of aids |
| 02/03/1993 | EP0525917A2 Double-stranded RNA correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles |
| 02/03/1993 | EP0525588A2 Production of pradimicin antibiotics by actinomadura strain |
| 02/03/1993 | EP0525499A1 Amide derivatives of antibiotic A 40926 |
| 02/03/1993 | EP0525145A1 Process for producing ergolin derivatives |
| 02/03/1993 | EP0525106A1 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents |
| 02/03/1993 | EP0525083A1 Erythromycin derivatives |
| 02/03/1993 | EP0525057A1 Antimicrobial quinolonyl lactams |
| 02/03/1993 | EP0524997A1 2'-o-alkyl nucleotides and polymers containing them. |
| 02/03/1993 | EP0524961A1 Azo-derivatives, pharmaceutical preparations containing them, and their use against aids. |
| 02/03/1993 | EP0346343B1 Anti-viral therapeutic composition |
| 02/03/1993 | CN1068570A Antiviral combinations |
| 02/02/1993 | US5183882 2'-deoxy-2'-methylidenecytidine dihydrate, methods for its production and compositions |
| 02/02/1993 | US5183826 Antiviral agent |
| 02/02/1993 | US5183659 Protection of equines against Streptococcus equi |
| 02/02/1993 | US5183658 A pathogen of hemorrhagic fever with renal syndrome; strain from human body is injected to one-day old mouse, raised to ten days, paralyzing and cutting head apart of rat to take brain, purification, inactivation and addition of adjuvant |
| 02/02/1993 | CA2075163A1 A87689 compounds |
| 02/01/1993 | CA2071140A1 Production of pradimicin antibiotics by fermentation |
| 01/28/1993 | DE4108395A1 Verwendung von oxazolo-(2,3-a)isoindol-und imidazo(2,1-a)-isoindol-derivaten als antivirale arzneimittel sowie neue oxazolo(2,3-a)isoindol-derivaten Use of oxazolo- (2,3-a) isoindole-and imidazo (2,1-a) -isoindol derivatives as antiviral drug as well as new -oxazolo (2,3-a) isoindole derivatives |
| 01/27/1993 | EP0524899A1 Recombinant DNA molecules coding for the VB2 T cell receptor, method of preparation, antibodies and medicaments containing them |
| 01/27/1993 | EP0524796A1 Use of essential fatty acids in the preparation of a medicament for the treatment of AIDS |
| 01/27/1993 | EP0524672A1 CCV vaccine |
| 01/27/1993 | EP0524632A1 Pleuromutilin complexes |
| 01/27/1993 | EP0524602A2 Compositions for the treatment of inflammations of the skin |
| 01/27/1993 | EP0524579A1 Improved oral dosing formulations of dideoxy purine nucleosides |
| 01/27/1993 | EP0524517A1 Substituted 3,4-dihydronaphthalenes, medicament containing them and process for their preparation |
| 01/27/1993 | EP0524439A1 Novel cyclohexane and tetrahydropyran derivatives and antifungal compositions containing these derivatives |
| 01/27/1993 | EP0524421A1 Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use |
| 01/27/1993 | EP0524283A1 Pharmaceutical product for treating viral diseases |
| 01/27/1993 | EP0524212A1 Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases |
| 01/27/1993 | CN1068333A Pharmacologically active hydrazine derivatives and processes for preparation thereof |
| 01/27/1993 | CN1068266A Vaccine and treatment method for human immunodeficiency virus |
| 01/26/1993 | WO1993001823A1 Intestine colonizing lactobacilli |
| 01/26/1993 | US5182265 Pharmacologically active peptide derivatives and pharmaceutical preparations containing them |
| 01/26/1993 | US5182109 Vaccine preparation comprising a bacterial toxin adjuvant |